Australia TGA ARTG record

Glaucoma shunt

Australia TGA ARTG Registered Device · RQSolutions Medical Devices Distribution Support · Glaukos Corporation · Class IIb · Started January 17, 2022

Good Name: RQSolutions Medical Devices Distribution Support - Glaucoma shunt

Device classification

Risk Class: Class IIb
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: January 17, 2022
Effective Date: January 17, 2022

Sponsor

Name: RQSolutions Medical Devices Distribution Support

Manufacturer

Name: Glaukos Corporation
Country: United States of America
Address: 229 Avenida Fabricante, San Clemente, CA, 92672

Intended purpose

The MicroShunt is intended for reduction of intraocular pressure in eyes of patients with primary open angle glaucoma where IOP remains uncontrollable while on maximum tolerated medical therapy and/or where glaucoma progression warrants surgery.

About this record

Access comprehensive regulatory information for Glaucoma shunt in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by RQSolutions Medical Devices Distribution Support, manufactured by Glaukos Corporation in United States of America. The device registration started on January 17, 2022.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.